Immune monitoring in COVID-19 patients

Key facts

Disease
COVID-19
start year
2020
Funder
NWO Netherlands
Principal Investigator
Prof dr CHJ van Eijck
Research Location
Netherlands
Lead Research Institution
Erasmus MC
Research Priority Alignment
N/A

Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

Currently it is not clear which patients who are admitted to the hospital with a SARS-CoV-2 infection will benefit from treatment or die. Clearly, the balanced immune system is lost in some of the SARS-CoV-2 infected patients which contributes to the progression in disease. We believe that monitoring the immunological changes induced by the SARS-CoV-2 virus will lead to discovering prognostic or predictive markers that may assist in decision making and offers therapeutic options.

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Development and Validation of the Intimate Partner Violence Workplace Disruptions Assessment (IPV-WDA).

Elucidating directed neural dynamics of scene construction across memory and imagination

Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.

Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of <i>Solanum lycopersicum</i> Detected by Long-Read Sequencing.

Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership.

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.